TheFlyOnTheWall dated July 12, 2013
Can we sell our shares next February after some results? Every development stage biotech company needs cash, that's for sure. But we can use less dilution if we are not at this very depressed price.
When CNDO does an ATM they can set any minimum price parameters/requirements that they want. Having the shelf is just an option for the company. Like I said there is no downside.
Does that mean that dilution is coming and we can see price drop in future
200m is lot if shares
Its just the "up to" amount authorized for ATMs. Doesn't mean anything.